IKKβ siRNA

**IKKβ siRNA** refers to a small interfering RNA (siRNA) compound that specifically targets the messenger RNA (mRNA) of the *inhibitor of nuclear factor kappa-B kinase subunit beta* (IKKβ) gene. IKKβ is a protein kinase that plays a key role in the activation of the **NF-κB signaling pathway**, which is involved in cellular responses to inflammation, immunity, stress, and cell survival. By introducing siRNA molecules designed to be complementary to the IKKβ mRNA, IKKβ expression can be transiently and efficiently **silenced** via the RNA interference (RNAi) mechanism—leading to decreased translation of IKKβ protein and subsequent inhibition of downstream NF-κB activity[1][2][3][4][5]. IKKβ siRNA has been demonstrated in preclinical studies to: - Decrease IKKβ protein and mRNA levels in various cell types and animal models[2][3][4][5]. - Inhibit activation of NF-κB and downstream inflammatory mediators[2][3][4][5]. - Reduce P-glycoprotein overexpression and seizure susceptibility in a rat model of epilepsy[3]. - Prevent inflammatory responses, fibrosis, and injury in models of renal and ocular disease[4][5]. - Protect insulin signaling and glucose uptake from inflammatory inhibition in cell-based models[2]. This compound has been primarily investigated for its utility as a molecular tool and potential **therapeutic agent** in disease states involving aberrant IKKβ/NF-κB signaling, such as cancer, inflammatory conditions, fibrosis, diabetes-related insulin resistance, and drug-resistant epilepsy[2][3][4][5][9].

Other names

siRNA targeting IKKβIKKβ-targeting siRNAIKKβ-siRNA